Pricing Log in Create free account

CorMedix Inc (CRMD) vs Prothena Corporation plc (PRTA)

CorMedix Inc and Prothena Corporation plc are both Biotechnology companies. CorMedix Inc and Prothena Corporation plc are of similar size ($433.4M and $421.5M). Prothena Corporation plc has negative trailing earnings, so its P/E is not meaningful; CorMedix Inc trades at 2.3×. Prothena Corporation plc grew revenue faster over the last twelve months: 427.3% against 280.5%. CorMedix Inc has the higher net margin (40.5% vs −80.7%) and the higher return on invested capital (38.8% vs 0.00%). Across the 18 metrics below, CorMedix Inc leads on 14 and Prothena Corporation plc on 4.

Valuation

Metric CRMD PRTA Biotechnology median
P/E 2.28 n/m 10.64
P/S 0.93 7.89 9.59
P/B 0.94 1.50 2.15
Price to free cash flow 1.72 n/m 26.07
EV/EBITDA 1.26 n/m 0.65
EV/Sales 0.69 2.60 9.45
Earnings yield 43.82% (10.06%) (34.69%)
Free cash flow yield 58.04% (14.13%) (24.02%)

Profitability

Metric CRMD PRTA Biotechnology median
Gross margin 82.78% 100.00% 65.59%
Operating margin 46.95% (101.80%) 0.00%
Net margin 40.49% (80.67%) 0.00%
Free cash flow margin 54.17% (111.49%) 0.00%
Return on equity 54.93% (14.39%) (51.96%)
Return on assets 32.36% (12.54%) (46.06%)
Return on invested capital 38.84% 0.00% 0.00%

Growth

Metric CRMD PRTA Biotechnology median
Revenue growth (TTM) 280.50% 427.32% 4.59%
EPS growth (last fiscal year) 780.00% (99.56%) 29.88%
Revenue growth, 5-year CAGR 305.79% 62.56% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRMD PRTA Biotechnology median
Debt to equity 0.32 0.00 0.00
Current ratio 2.56 25.05 4.86
Net debt to EBITDA (0.02) 1.46 1.01

Dividend

Metric CRMD PRTA Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric CRMD PRTA Biotechnology median
Market cap 433.37m 421.47m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack